全球重组蛋白製造服务市场研究报告 - 2023 年至 2030 年产业分析、规模、份额、成长、趋势与预测

预计到 2030 年，全球重组蛋白製造服务市场的市场规模将从 2022 年的 42.9 亿美元达到近 164.5 亿美元，2023-2030 年研究期间的CAGR为 18.29%。

重组蛋白製造服务是指生物技术和合约製造组织 (CMO) 提供的用于生产各种用途的重组蛋白的流程和设施。重组蛋白是由基因工程生物体（通常是细菌、酵母、哺乳动物细胞，甚至植物）产生的，以表达特定的目的蛋白。这些蛋白质用于各个领域，包括製药、生物技术、研究、诊断和工业应用。

市场动态：

由于几个关键因素，重组蛋白製造服务市场正在经历成长。对单株抗体和疫苗等生物药物的需求推动了生物製药产业的扩张，这是主要驱动力。生物药物越来越多地用于治疗各种疾病，因此需要生产这些服务所提供的重组蛋白。生命科学和生物技术的研发活动、基因工程的进步以及合约製造的外包趋势进一步刺激了需求。慢性病盛行率的上升、COVID-19 强调的大流行防范的必要性以及蛋白质表现和纯化技术的不断进步都促进了市场的成长。监管审批，尤其是生物製药领域的监管审批，确保了对可靠且合规的製造服务的需求。新兴市场和服务提供者提供的客製化选项也发挥了作用。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球重组蛋白製造服务市场的每个细分市场进行包容性评估。重组蛋白製造服务产业的成长和趋势为本研究提供了整体方法。

区域分析：

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲重组蛋白製造服务市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。重组蛋白製造服务市场的主要参与者包括 Lonza、Boehringer Ingelheim International GmbH、FUJIFILM Diosynth Biotechnologies、Merck KGaA、Bruker (InVivo BioTech Services GmbH)、Sino Biological, Inc.、GenScript、Kaneka Corporation (Kaneka Eurogentec SA)、Polyplus转染（Xpress Biologics），Boster Biological Technology，Trenzyme GmbH。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

• 报告说明
  • 客观的
  • 目标受众
  • 独特的销售主张 (USP) 和产品
• 研究范围
• 研究方法论
  • 市场研究过程
  • 市场研究方法论

第 2 章：执行摘要

• 市集亮点
• 全球市场概况

第 3 章：重组蛋白製造服务 - 产业分析

• 简介 - 市场动态
• 市场驱动因素
• 市场限制
• 机会
• 产业动态
• 波特五力分析
• 市场吸引力分析
  • 按服务类型分類的市场吸引力分析
  • 按宿主细胞分類的市场吸引力分析
  • 最终用户的市场吸引力分析
  • 市场吸引力分析：按地区

第 4 章：价值链分析

• 价值链分析
• 原料分析
  • 原料清单
  • 原料厂商清单
  • 主要原物料价格走势
• 潜在买家名单
• 行销管道
  • 直效行销
  • 间接行销
  • 行销通路发展趋势

第 5 章：全球重组蛋白製造服务市场分析：依服务类型

• 按服务类型概述
• 历史和预测数据
• 按服务类型分析
• 临床前和临床服务
• 商业製作服务

第 6 章：全球重组蛋白製造服务市场分析：按宿主细胞

• 宿主细胞概述
• 历史和预测数据
• 宿主细胞分析
• 哺乳动物细胞
• 细菌细胞
• 昆虫细胞
• 酵母和真菌
• 其他的

第 7 章：全球重组蛋白製造服务市场分析：按最终用户

• 最终用户概述
• 历史和预测数据
• 最终用户分析
• 製药与生物技术公司
• 学术及研究机构

第 8 章：全球重组蛋白製造服务市场分析：依地理位置

• 区域展望
• 介绍
• 北美销售分析
  • 概览、历史与预测资料销售分析
  • 北美按细分市场销售分析
  • 北美按国家销售分析
  • 美国销售分析
  • 加拿大销售分析
  • 墨西哥销售分析
• 欧洲销售分析
  • 概览、历史与预测资料销售分析
  • 欧洲按细分市场销售分析
  • 欧洲按国家销售分析
  • 英国销售分析
  • 法国销售分析
  • 德国销售分析
  • 义大利销售分析
  • 俄罗斯销售分析
  • 欧洲其他地区销售分析
• 亚太地区销售分析
  • 概览、历史与预测资料销售分析
  • 亚太地区按细分市场销售分析
  • 亚太地区国家/地区销售分析
  • 中国销售分析
  • 印度销售分析
  • 日本销售分析
  • 韩国销售分析
  • 澳洲销售分析
  • 东南亚销售分析
  • 亚太地区其他地区销售分析
• 拉丁美洲销售分析
  • 概览、历史与预测资料销售分析
  • 拉丁美洲按细分市场销售分析
  • 拉丁美洲按国家销售分析
  • 巴西销售分析
  • 阿根廷销售分析
  • 秘鲁销售分析
  • 智利销售分析
  • 拉丁美洲其他地区销售分析
• 中东和非洲销售分析
  • 概览、历史与预测资料销售分析
  • 中东和非洲按细分市场销售分析
  • 中东和非洲国家销售分析
  • 沙乌地阿拉伯销售分析
  • 阿联酋销售分析
  • 以色列销售分析
  • 南非销售分析
  • 中东其他地区和非洲销售分析

第 9 章：重组蛋白製造服务公司的竞争格局

• 重组蛋白製造服务市场竞争
• 伙伴关係/协作/协议
• 併购
• 新产品发布
• 其他发展

第 10 章：公司简介

• 公司股份分析
• 市场集中度
• Lonza
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Boehringer Ingelheim International GmbH
• 公司简介
• 公司收入
• 产品
• 最近的发展
• FUJIFILM Diosynth Biotechnologies
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Merck KGaA
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Bruker (InVivo BioTech Services GmbH)
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Sino Biological Inc.
• 公司简介
• 公司收入
• 产品
• 最近的发展
• GenScript
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Kaneka Corporation (Kaneka Eurogentec SA)
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Polyplus Transfection (Xpress Biologics)
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Boster Biological Technology
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Trenzyme GmbH
• 公司简介
• 公司收入
• 产品
• 最近的发展

注意 - 在公司概况中，财务详细资讯和近期发展视情况而定，或者如果是私人公司，则可能不包括在内

The global demand for Recombinant Proteins Manufacturing Services Market is presumed to reach the market size of nearly USD 16.45 BN by 2030 from USD 4.29 BN in 2022 with a CAGR of 18.29% under the study period 2023 - 2030.

Recombinant protein manufacturing services refer to the processes and facilities offered by biotechnology and contract manufacturing organizations (CMOs) to produce recombinant proteins for various purposes. Recombinant proteins are produced by genetically engineering organisms, typically bacteria, yeast, mammalian cells, or even plants, to express specific proteins of interest. These proteins are used in various fields, including pharmaceuticals, biotechnology, research, diagnostics, and industrial applications.

MARKET DYNAMICS:

The recombinant proteins manufacturing services market is experiencing growth due to several key factors. The expansion of the biopharmaceutical industry, driven by the demand for biologic drugs like monoclonal antibodies and vaccines, is a primary driver. Biologic drugs are increasingly used in treating various diseases, necessitating the production of recombinant proteins, which these services provide. Research and development activities in life sciences and biotechnology, advancements in genetic engineering, and the outsourcing trend in contract manufacturing further boost demand. The rising prevalence of chronic diseases, the imperative for pandemic preparedness highlighted by COVID-19, and ongoing technological advancements in protein expression and purification techniques contribute to the market's growth. Regulatory approvals, especially in the biopharmaceutical sector, ensure the demand for reliable and compliant manufacturing services. Emerging markets and the customization options service providers offer also play a role.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of recombinant proteins manufacturing services. The growth and trends of recombinant proteins manufacturing services industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the recombinant proteins manufacturing services market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Service Type

• Pre-Clinical & Clinical Services
• Commercial Production Services

By Host Cell

• Mammalian Cells
• Bacterial Cells
• Insect Cells
• Yeast & Fungi
• Others

By End-User

• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Recombinant Proteins Manufacturing Services market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Recombinant Proteins Manufacturing Services market include Lonza, Boehringer Ingelheim International GmbH, FUJIFILM Diosynth Biotechnologies, Merck KGaA, Bruker (InVivo BioTech Services GmbH), Sino Biological, Inc., GenScript, Kaneka Corporation (Kaneka Eurogentec S.A), Polyplus Transfection (Xpress Biologics), Boster Biological Technology, Trenzyme GmbH. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . RECOMBINANT PROTEINS MANUFACTURING SERVICES - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Service Type
  • 3.7.2 Market Attractiveness Analysis By Host Cell
  • 3.7.3 Market Attractiveness Analysis By End-User
  • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL RECOMBINANT PROTEINS MANUFACTURING SERVICES MARKET ANALYSIS BY SERVICE TYPE

• 5.1 Overview by Service Type
• 5.2 Historical and Forecast Data
• 5.3 Analysis by Service Type
• 5.4 Pre-Clinical & Clinical Services Historic and Forecast Sales by Regions
• 5.5 Commercial Production Services Historic and Forecast Sales by Regions

6 . GLOBAL RECOMBINANT PROTEINS MANUFACTURING SERVICES MARKET ANALYSIS BY HOST CELL

• 6.1 Overview by Host Cell
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Host Cell
• 6.4 Mammalian Cells Historic and Forecast Sales by Regions
• 6.5 Bacterial Cells Historic and Forecast Sales by Regions
• 6.6 Insect Cells Historic and Forecast Sales by Regions
• 6.7 Yeast & Fungi Historic and Forecast Sales by Regions
• 6.8 Others Historic and Forecast Sales by Regions

7 . GLOBAL RECOMBINANT PROTEINS MANUFACTURING SERVICES MARKET ANALYSIS BY END-USER

• 7.1 Overview by End-User
• 7.2 Historical and Forecast Data
• 7.3 Analysis by End-User
• 7.4 Pharmaceutical & Biotechnology Companies Historic and Forecast Sales by Regions
• 7.5 Academic & Research Institutes Historic and Forecast Sales by Regions

8 . GLOBAL RECOMBINANT PROTEINS MANUFACTURING SERVICES MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.3.2. North America By Segment Sales Analysis
  • 8.3.3. North America By Country Sales Analysis
  • 8.3.4. United State Sales Analysis
  • 8.3.5. Canada Sales Analysis
  • 8.3.6. Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.4.2. Europe by Segment Sales Analysis
  • 8.4.3. Europe by Country Sales Analysis
  • 8.4.4. United Kingdom Sales Analysis
  • 8.4.5. France Sales Analysis
  • 8.4.6. Germany Sales Analysis
  • 8.4.7. Italy Sales Analysis
  • 8.4.8. Russia Sales Analysis
  • 8.4.9. Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.5.2. Asia Pacific by Segment Sales Analysis
  • 8.5.3. Asia Pacific by Country Sales Analysis
  • 8.5.4. China Sales Analysis
  • 8.5.5. India Sales Analysis
  • 8.5.6. Japan Sales Analysis
  • 8.5.7. South Korea Sales Analysis
  • 8.5.8. Australia Sales Analysis
  • 8.5.9. South East Asia Sales Analysis
  • 8.5.10. Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.6.2. Latin America by Segment Sales Analysis
  • 8.6.3. Latin America by Country Sales Analysis
  • 8.6.4. Brazil Sales Analysis
  • 8.6.5. Argentina Sales Analysis
  • 8.6.6. Peru Sales Analysis
  • 8.6.7. Chile Sales Analysis
  • 8.6.8. Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.7.2. Middle East & Africa by Segment Sales Analysis
  • 8.7.3. Middle East & Africa by Country Sales Analysis
  • 8.7.4. Saudi Arabia Sales Analysis
  • 8.7.5. UAE Sales Analysis
  • 8.7.6. Israel Sales Analysis
  • 8.7.7. South Africa Sales Analysis
  • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE RECOMBINANT PROTEINS MANUFACTURING SERVICES COMPANIES

• 9.1. Recombinant Proteins Manufacturing Services Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10 . COMPANY PROFILES OF RECOMBINANT PROTEINS MANUFACTURING SERVICES INDUSTRY

• 10.1. Company Share Analysis
• 10.2. Market Concentration Rate
• 10.3. Lonza
  • 10.3.1. Company Overview
  • 10.3.2. Company Revenue
  • 10.3.3. Products
  • 10.3.4. Recent Developments
• 10.4. Boehringer Ingelheim International GmbH
  • 10.4.1. Company Overview
  • 10.4.2. Company Revenue
  • 10.4.3. Products
  • 10.4.4. Recent Developments
• 10.5. FUJIFILM Diosynth Biotechnologies
  • 10.5.1. Company Overview
  • 10.5.2. Company Revenue
  • 10.5.3. Products
  • 10.5.4. Recent Developments
• 10.6. Merck KGaA
  • 10.6.1. Company Overview
  • 10.6.2. Company Revenue
  • 10.6.3. Products
  • 10.6.4. Recent Developments
• 10.7. Bruker (InVivo BioTech Services GmbH)
  • 10.7.1. Company Overview
  • 10.7.2. Company Revenue
  • 10.7.3. Products
  • 10.7.4. Recent Developments
• 10.8. Sino Biological Inc.
  • 10.8.1. Company Overview
  • 10.8.2. Company Revenue
  • 10.8.3. Products
  • 10.8.4. Recent Developments
• 10.9. GenScript
  • 10.9.1. Company Overview
  • 10.9.2. Company Revenue
  • 10.9.3. Products
  • 10.9.4. Recent Developments
• 10.10. Kaneka Corporation (Kaneka Eurogentec S.A)
  • 10.10.1. Company Overview
  • 10.10.2. Company Revenue
  • 10.10.3. Products
  • 10.10.4. Recent Developments
• 10.11. Polyplus Transfection (Xpress Biologics)
  • 10.11.1. Company Overview
  • 10.11.2. Company Revenue
  • 10.11.3. Products
  • 10.11.4. Recent Developments
• 10.12. Boster Biological Technology
  • 10.12.1. Company Overview
  • 10.12.2. Company Revenue
  • 10.12.3. Products
  • 10.12.4. Recent Developments
• 10.13. Trenzyme GmbH
  • 10.13.1. Company Overview
  • 10.13.2. Company Revenue
  • 10.13.3. Products
  • 10.13.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• Analysis by Service Type (USD MN)
• Pre-Clinical & Clinical Services Market Sales by Geography (USD MN)
• Commercial Production Services Market Sales by Geography (USD MN)
• Analysis Market by Host Cell (USD MN)
• Mammalian Cells Market Sales by Geography (USD MN)
• Bacterial Cells Market Sales by Geography (USD MN)
• Insect Cells Market Sales by Geography (USD MN)
• Yeast & Fungi Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Analysis by End-User (USD MN)
• Pharmaceutical & Biotechnology Companies Market Sales by Geography (USD MN)
• Academic & Research Institutes Market Sales by Geography (USD MN)
• Global Recombinant Proteins Manufacturing Services Market Sales by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate by Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• South East Asia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Recombinant Proteins Manufacturing Services Report
• Market Research Process
• Market Research Methodology
• Global Recombinant Proteins Manufacturing Services Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Service Type
• Market Attractiveness Analysis by Host Cell
• Market Attractiveness Analysis by End-User
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis by Service Type (USD MN)
• Pre-Clinical & Clinical Services Market Sales by Geography (USD MN)
• Commercial Production Services Market Sales by Geography (USD MN)
• Global Market Analysis by Host Cell (USD MN)
• Mammalian Cells Market Sales by Geography (USD MN)
• Bacterial Cells Market Sales by Geography (USD MN)
• Insect Cells Market Sales by Geography (USD MN)
• Yeast & Fungi Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market Analysis by End-User (USD MN)
• Pharmaceutical & Biotechnology Companies Market Sales by Geography (USD MN)
• Academic & Research Institutes Market Sales by Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.